Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2019 | R/R CLL: combination therapy and tailored treatment

Lydia Scarfo, MD, Vita-Salute San Raffaele University, Milan, Italy, talks about the combination of ibrutinib and venetoclax and tailoring chronic lymphocytic leukemia (CLL) treatment based on response. Dr Scarfo goes on to discuss the main challenges being faced in CLL. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.